SARC Talk Episode 36 - Dr. Michael Wagner - EHE

In this episode, we welcome Dr. Michael Wagner, MD, SeniorPhysician and Clinical Research Director at Dana-Farber Cancer Institute. Dr. Wagner shares his journey into the field of sarcoma and his leadership as Principal Investigator of SARC046, a pivotal study of nab-sirolimus in epithelioid hemangioendothelioma (EHE). We explore how multi-institutional collaboration throughSARC and federal partnerships helped bring this study from concept to activation, the critical role of patient advocacy—particularly the EHE Foundation—and what it takes to build successful sarcoma programs across institutions.